| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |